Related Experiment Video

Updated: Aug 6, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Dyslipidemia in menopause: mechanisms and management

Peter F Schnatz1, J David Schnatz

  • 1Department of Obstetrics and Gynecology & Internal Medicine, The University of Connecticut School of Medicine, Farmington, USA. pschnat@harthosp.org

Obstetrical & Gynecological Survey
|August 22, 2006
PubMed

Insights

Women face higher cardiovascular disease mortality than men, with risk increasing postmenopause. Early screening and management of dyslipidemia are crucial for prevention.

Area of Science:

  • Cardiology
  • Women's Health
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in women, with incidence escalating postmenopause.
  • Physicians caring for menopausal women need to address modifiable risk factors for coronary artery disease.
  • Dyslipidemia is a significant, easily diagnosable risk factor.

Purpose of the Study:

  • To provide an overview of dyslipidemia in women.
  • To outline screening recommendations and interpretation of lipid results.
  • To guide management or referral for patients with dyslipidemia.

Main Methods:

  • Review of National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) guidelines.
  • Discussion of dyslipidemia screening protocols.
  • Guidance on interpreting lipid profiles.

Main Results:

  • Women have a higher annual mortality rate from CVD than men.
  • CVD incidence significantly rises in postmenopausal women.
  • Dyslipidemia screening and management are key preventive strategies.

Conclusions:

  • Physicians should be equipped to screen, diagnose, and manage dyslipidemia in menopausal women.
  • Adherence to NCEP ATP III guidelines is recommended for lipid management.
  • Effective management of dyslipidemia can prevent adverse cardiovascular outcomes in women.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...